News-Medical.Net on MSN

Proimmune Ltd introduces Prove® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.
Labroots

Transformative Technologies in Pancreatic Cancer: Multi-omic Insights and Organoid Innovation

In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our ...
TipRanks on MSN

Standard BioTools Inc. Reports Q3 2025 Financial Results

Standard Biotools Inc ( ($LAB) ) has released its Q3 earnings. Here is a breakdown of the information Standard Biotools Inc presented to its ...
PharmaTimes

ProImmune unveils ProVE SL monomers to boost T cell research

ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science ...
Pharmabiz

ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility

ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...